Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
Freenome Holdings, Inc.
Freenome’s SimpleScreen™ CRC Blood-Based Test Included in Updated ACS Colorectal Cancer Screening Guideline
May 27, 2026
Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer
March 18, 2026
Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection
January 12, 2026
Freenome Delivers Improved Performance in Its Colorectal Cancer Blood Test with Sensitivity of 85% for CRC and 22% for Advanced Precancerous Lesions
January 6, 2026
Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform
December 11, 2025